首页|Janus激酶抑制剂在皮肤病中的应用进展

Janus激酶抑制剂在皮肤病中的应用进展

Advances in the Application of Janus Kinase Inhibitors in Skin Diseases

扫码查看
Janus激酶-信号转导子和转录激活子(JAK-STAT)信号通路在炎症免疫性疾病及肿瘤的发病机制中发挥重要作用.JAK抑制剂作为一种小分子靶向药物,很可能是治疗此类疾病的新方法.文章主要阐述其在皮肤科领域中的应用进展.
Janus kinase-signal transducer and transcriptional activator signaling pathway plays an important role in the pathogenesis of inflammatory diseases,immune diseases and tumors.As a small molecule targeted drug,JAK inhibitor is likely to be a new method for the treatment of such diseases.The study mainly describes its application progress in dermatology.

Janus Kinase inhibitorDermatologyCancer

安骏腾、赵娜、李倩男、郭雯

展开 >

河北省沧州中西医结合医院皮肤科,河北 沧州 061000

Janus激酶抑制剂 皮肤病 肿瘤

2024

黑龙江医学
中华医学会黑龙江分会

黑龙江医学

影响因子:0.714
ISSN:1004-5775
年,卷(期):2024.48(19)